Review of Schistosoma japonicum Diagnostic Techniques and Prevalence in China, 2015-2026

A review document provides an update on diagnostic technologies and epidemiological features of Schistosoma japonicum in China from 2015 onward. It aggregates data from 37 studies involving 46,910,186 human serum samples and 24 studies covering 14,381 wild rodents. The document was authored by Fen Chen and last updated on 2026-05-28.

Use Cases

• Compare the performance of traditional versus emerging diagnostic techniques based on the review of methods like Kato-Katz, PCR, and CRISPR/Cas systems.
• Analyze regional variation in seroprevalence based on aggregated data from 10 Chinese provinces.
• Assess the role of wild rodents as reservoir hosts based on reported infection rates in species like Rattus norvegicus.
• Inform surveillance program design based on the review's conclusions about integrating sensitive molecular diagnostics.

Strengths

• Aggregates data from a large human sample size of 46,910,186 serum samples.
• Reports specific prevalence figures with confidence intervals, such as an overall human seroprevalence of 1.54% and a rodent prevalence of 8.97%.
• Focuses on a defined time period (literature from 2015 onward).

Limitations

• The dataset is a 15.9 KB DOCX review document, not a primary data table; row and column structures are unknown.
• Description metadata is limited; actual data quality requires manual inspection after download.
• Data may reflect geographic bias inherent to the reviewed studies focused on China.

Provenance

Source

Fen Chen via figshare.

Collection Method

Narrative review and descriptive aggregation of published studies.

Time Range

2015 to 2026.

Freshness

Last updated 2026-05-28 04:48:09; freshness should be verified.

Geography

China, with specific mention of 10 provinces including Fujian and Yunnan.